Business Support Services

Page 1

Cellular Biomedicine Group announces positive phase I results from CAR-T CD30 immuno-oncology clinical development program

Friday, 22 May 2015 09:17am EDT

Cellular Biomedicine Group:Says encouraging clinical data from its Chimeric Antigen Receptor (CAR-T) CD30-positive Hodgkin's lymphoma immuno-oncology clinical development program.Says results of this trial to date demonstrated that five out of seven patients responded to the treatment.CD30-directed CAR-T cell therapy was demonstrated in this trial to be safe, feasible and efficient.

Korea Electronic Power Industrial Development to sell entire stake in Korea-based company

Friday, 22 May 2015 04:11am EDT

Korea Electronic Power Industrial Development Co Ltd:To sell 1,020,000 shares of a Korea-based company, which is engaged in development and provision of biofuels energy.Transaction price of 153 mln won.Expected transaction settlement date of June 30.

Multiconsult : Bookbuilding successfully completed, share priced at NOK 78

Friday, 22 May 2015 01:30am EDT

Multiconsult AS:Says bookbuilding successfully completed - offer shares priced at 78 Norwegian crowns per share.Offer price at 78 crowns per share implies a market capitalisation of Multiconsult of about 2,047 million crowns.Trading in shares of Multiconsult on Oslo Stock Exchange will commence on May 22.A total of 12,190,000 shares (including over-allotted shares) were allotted in the offering, of which 11,678,556 of the shares were allotted to investors in the Institutional Offering and 511,444 of the shares were allotted to investors in the retail offering.Following completion of the offering, Multiconsult will have in excess of 2,000 shareholders.

CCA International to acquire Data Base Factory

Thursday, 21 May 2015 11:39am EDT

CCA International SA:Has announced that it has signed an exclusivity agreement for acquisition of commercial CRM specialist, Data Base Factory.Final agreements are expected to be signed over summer once consultation process with relevant affected employee representatives is complete.

Booz Allen Hamilton Holding Corp gives FY 2016 guidance below analysts' estimates

Thursday, 21 May 2015 07:00am EDT

Booz Allen Hamilton Holding CorpL:Expects FY 2016 revenue to be roughly flat, with a range of two percent growth to a two percent decline.Expects FY 2016 diluted EPS to be in the range of $1.55 to $1.65.Expects FY 2016 adjusted diluted EPS to be on the order of $1.60 to $1.70.Reported revenue of $5.27 billion in FY 2015.FY 2016 revenue of $5.450 billion and EPS of $1.73 -Thomson Reuters I/B/E/S.

Earth Science Tech Inc announces management change - Form 8k

Thursday, 21 May 2015 06:05am EDT

Earth Science Tech Inc:Says Harvey Katz was terminated as CEO for cause on May 9, and on May 10 he submitted his resignation as CEO and director.Says Cohen was appointed May 9, as acting CEO.Says he was appointed CFO of the company on Feb. 15.

ISS says FY 2015 guidance unchanged

Thursday, 21 May 2015 02:23am EDT

ISS A/S:Says FY 2015 outlook for organic growth, operating margin and cash conversion remains unchanged.Organic growth is expected to be 2 pct - 4 pct.Operating margin in FY 2015 is expected to be above the 5.6 pct realised in FY 2014.Cash conversion is expected to remain above 90 pct.

THC FARMACEUTICALS appoints new CEO and Chairman - Form 8-K

Wednesday, 20 May 2015 05:15pm EDT

THC FARMACEUTICALS:Says on May 15, Former U.S. Senator Mike Gravel was appointed Chief Executive Officer of the Company and elected to serve on board of directors as Chairman of the Board.

LCA Holdings amends consolidated full-year outlook for FY 2015; announces debt forgiveness and expects extraordinary profit for FY 2015

Wednesday, 20 May 2015 12:30pm EDT

LCA Holdings Corporation:Says the company amended the consolidated full-year outlook for the FY ending May 2015.Revenue forecast decreased to 200 million yen from 1,630 million yen.Operating profit forecast has been amended to an undermined value from 250 million yen.Ordinary profit forecast has been amended to an undermined value from 36 million yen.Net profit forecast has been amended to an undermined value from 58 million yen.Earnings per share has been amended to an undermined value from 0.13 yen.Comments that cancellation of the sales contract, accounting and policies of liquidated damages to be decided are the main reasons for the forecast.Announces debt forgiveness of 280,515,000 yen in total by an individual and two entities, as financial support for the company.Expects extraordinary profit of 243,416,000 yen for this debt forgiveness, for FY 2015.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.